HBKU college of health and life sciences talk spotlights renowned scientist's breakthrough on cell death-driven inflammation

Genentech's Dr. Vishva M. Dixit discusses a new finding in cell death research that could generate novel therapeutics

  
HBKU college of health and life sciences talk spotlights renowned scientist's breakthrough on cell death-driven inflammation

Doha: – The College of Health and Life Sciences (CHLS) at Hamad Bin Khalifa University (HBKU) recently presented a talk by Dr. Vishva M. Dixit, Vice President of Early Discovery Research at Genentech Inc. and one of the world’s most eminent biomedical science researchers.

Titled The Non-Canonical Inflammasome Pathway, the seminar on September 16 was an opportunity for HBKU faculty, researchers, and graduate students to engage with a pioneering figure in the scientific community. Dr. Dixit’s publications rank among the most-cited in the world and his work explaining the molecular mechanisms of inflammation has become part of standard scientific textbooks. He also oversees Genentech’s postdoctoral fellowship program. The interactive discussions were moderated by Dr. Fadel Tissir, professor at CHLS.

Dr. Dixit presented an update on his team’s discovery that the protein ninjurin-1 (NINJ1) is an important driver of inflammation. His laboratory has recorded many pioneering research firsts that have defined the biochemical framework of the cell death pathway. This latest finding on the role of NINJ1 is widely recognized to have potential implications for novel strategies and therapeutics to target cell death-driven inflammation, and diseases with a prominent inflammatory component.

Commenting after the talk, Dr. Omar Khan, assistant professor at CHLS, said: “Dr. Dixit’s seminal biomedical research has advanced the scientific community’s understanding of cell death signaling and inflammation, and how it can help the discovery of innovative treatments. For the CHLS and HBKU community, his talk was a tremendous learning opportunity. It will certainly enrich our work with cutting-edge knowledge to address pressing national and regional health challenges, and educate future generations of biomedical research scientists.”

For more information on the work of the College of Health and Life Sciences, please visit www.chls.hbku.edu.qa 

-Ends- 

About Hamad Bin Khalifa University

Innovating Today, Shaping Tomorrow

Hamad Bin Khalifa University (HBKU), a member of Qatar Foundation for Education, Science, and Community Development (QF), was founded in 2010 as a research-intensive university that acts as a catalyst for transformative change in Qatar and the region while having global impact. Located in Education City, HBKU is committed to building and cultivating human capacity through an enriching academic experience, innovative ecosystem, and unique partnerships. HBKU delivers multidisciplinary undergraduate and graduate programs through its colleges, and provides opportunities for research and scholarship through its institutes and centers. For more information about HBKU, visit www.hbku.edu.qa 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases